Recent Advances and Novel Strategies in Formulation Development: SMEDDS

Abstract

Drug delivery systems that self-microemulsify (SMEDDS) have become a viable solution to the problems caused by poorly soluble medications. When these systems are diluted in aqueous media, a combination of oil, surfactant, cosurfactant, and drug spontaneously forms microemulsions. Owing to this special characteristic, SMEDDS can improve drug absorption, solubility, and overall bioavailability. The increasing frequency of poorly soluble compounds has demonstrated the urgency of developing creative formulation techniques. By designing a suitable environment for drug release and absorption, SMEDDS present an interesting approach. Microemulsions created by SMEDDS help to increase the effective surface area of the drug, thereby promoting its disintegration and absorption from the gastrointestinal system. SMEDDS have been employed in a range of therapeutic contexts, including topical, parenteral, and oral administration. For poorly soluble drugs, SMEDDS can significantly improve oral bioavailability, thus allowing smaller doses and fewer dosing intervals. By attaining continuous release during parenteral administration, SMEDDS can prolong the therapeutic effects of drugs. When applied topically, SMEDDS can enhance skin penetration and help medications reach target regions. In addition to their traditional use, SMEDDS are under investigation for other therapeutic fields based on nasal and ocular distribution. These methods of administration pose special challenges given the delicate nature of these tissues and the need for precise medicine delivery. SMEDDS enable a controlled and continuous release of drugs by reducing pain and improving therapeutic effectiveness, thus perhaps providing cures.

In conclusion, SMEDDSs are a potential approach to increasing the bioavailability and potency of poorly soluble drugs. This study aims to provide a comprehensive overview of the current state of research in this field by elucidating the underlying concepts of SMEDDSs and exploring recent breakthroughs in their formulation and implementation. SMEDDSs have a promising future due to their potential to alter modes of drug delivery and improve patient outcomes.